412 related articles for article (PubMed ID: 19376179)
1. Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers.
Torrell JM; Aumatell CM; Ramos SM; Mestre LG; Salas CM
Vaccine; 2009 Jun; 27(30):4074-7. PubMed ID: 19376179
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.
López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E
Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
4. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
5. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
6. Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS).
Gabutti G; Aquilina M; Cova M; Giuffrida S; Lizioli A; Protano D; Scrivano F; Tomasi A; Cucchi A; Cavallaro A;
J Prev Med Hyg; 2012 Dec; 53(4):199-203. PubMed ID: 23469588
[TBL] [Abstract][Full Text] [Related]
7. Oral cholera vaccines: use in clinical practice.
Hill DR; Ford L; Lalloo DG
Lancet Infect Dis; 2006 Jun; 6(6):361-73. PubMed ID: 16728322
[TBL] [Abstract][Full Text] [Related]
8. [Travellers' compliance with the use of an oral cholera vaccine].
Cucchi A; Cova M; Merciadri GV; Serenelli C; Ghiselli G; Buriani O; Gabutti G
Ig Sanita Pubbl; 2010; 66(4):409-18. PubMed ID: 21132038
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study.
López-Gigosos R; Campins M; Calvo MJ; Pérez-Hoyos S; Díez-Domingo J; Salleras L; Azuara MT; Martínez X; Bayas JM; Ramón Torrell JM; Pérez-Cobaleda MA; Núñez-Torrón ME; Gorgojo L; García-Rodríguez M; Díez-Díaz R; Armadans L; Sánchez-Fernández C; Mejías T; Masuet C; Pinilla R; Antón N; Segarra P
Hum Vaccin Immunother; 2013 Mar; 9(3):692-8. PubMed ID: 23324573
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
Murray J; McFarland DA; Waldman RJ
Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of intestinal flora after oral vaccination with inactivated whole-cell/recombinant B subunit O139 cholera vaccine.
Wu HX; Chen Q; Li JD; Huang XF
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):220-2, 225. PubMed ID: 14965834
[TBL] [Abstract][Full Text] [Related]
13. [Community trial for safety and immunogenicity of oral-administered lyophilized rBS-WC cholera vaccine].
Chen Q; Yu S; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):330-3. PubMed ID: 9388905
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea.
López-Gigosos R; Garcia-Fortea P; Calvo MJ; Reina E; Diez-Diaz R; Plaza E
BMC Infect Dis; 2009 May; 9():65. PubMed ID: 19445712
[TBL] [Abstract][Full Text] [Related]
15. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.
Peltola H; Siitonen A; Kyrönseppä H; Simula I; Mattila L; Oksanen P; Kataja MJ; Cadoz M
Lancet; 1991 Nov; 338(8778):1285-9. PubMed ID: 1682684
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
[TBL] [Abstract][Full Text] [Related]
17. Oral vaccines for cholera control.
Chaturvedi S; Chaturvedi S
Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
[TBL] [Abstract][Full Text] [Related]
18. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
[TBL] [Abstract][Full Text] [Related]
19. Vaccinations for international travellers travelling from Greece.
Pavli A; Spilioti A; Lymperi I; Katerelos P; Maltezou HC
Travel Med Infect Dis; 2013; 11(4):225-30. PubMed ID: 23433917
[TBL] [Abstract][Full Text] [Related]
20. Statement on new oral cholera and travellers' diarrhea vaccination.
;
Can Commun Dis Rep; 2005 Jul; 31(ACS-7):1-11. PubMed ID: 15999424
[No Abstract] [Full Text] [Related]
[Next] [New Search]
